387-98197-99324
4 vaccinations
3 coded responses
43 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 024 / MA
- Registered
- 2021-04-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-10
Dose 1 — Pfizer-BioNTech
-
2021-04-11
Registered in v-safe
-
2021-04-11
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-12
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2021-04-13
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-14
- 2021-04-15
- 2021-04-16
- 2021-04-17
- 2021-04-24
-
2021-05-01
Dose 2 — Pfizer-BioNTech
- 2021-05-01
-
2021-05-02
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Itching · Headache · Be unable to workAdult check-in
-
2021-05-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Itching · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-05
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Itching · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-06
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Itching · Fatigue or tirednessAdult check-in
- 2021-05-07
- 2021-05-08
- 2021-05-15
- 2021-05-22
- 2021-05-29
- 2021-06-05
- 2021-06-12
- 2021-08-02
- 2021-10-30
-
2021-12-13
Dose 3 — Pfizer-BioNTechCo-administered: Other
- 2021-12-13
- 2021-12-14
- 2021-12-15
- 2021-12-16
- 2021-12-17
- 2021-12-18
- 2021-12-19
- 2021-12-20
- 2021-12-27
-
2022-01-03
Survey response — day 21, dose 3MedDRA: Headache, Oropharyngeal pain, Sinus disorder — Feeling: FairFree text: Sore throat, headache (likely from dryness of Colorado and my sinuses having trouble keeping up)MedDRA releases: 2024-11 · check-in free text available
-
2022-01-10
Survey response — day 28, dose 3MedDRA: Anosmia, Discharge, Headache, Nasopharyngitis, Oropharyngeal pain, Respiratory tract congestion — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Mild cold symptoms (headache, drainage/congestion, sore throat), loss of smellMedDRA releases: 2024-11 · check-in free text available
- 2022-01-17
- 2022-01-24
- 2022-03-14
-
2022-06-13
Survey response — 6 months, dose 3MedDRA: Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-06-13
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-06-14
-
2022-06-14
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-09-18
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-18
- 2022-10-23
- 2022-10-30
- 2022-12-18
- 2023-03-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-10 | Pfizer-BioNTech | |
| 2 | 2021-05-01 | Pfizer-BioNTech | |
| 3 | 2021-12-13 | Pfizer-BioNTech | Other |
| 4 | 2022-09-18 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-06-13 | Successful 2022-06-14 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 10 — day 21, dose 3
Symptoms: Sore throat, headache (likely from dryness of Colorado and my sinuses having trouble keeping up)
Release 10 — day 28, dose 3
Symptoms: Mild cold symptoms (headache, drainage/congestion, sore throat), loss of smell
Release 12 — 6 months, dose 3
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anosmia | · | · | ✓ |
| SD | Discharge | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Sinus disorder | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release